Zynerba Pharmaceuticals, Inc. NasdaqGM:ZYNE 13.77 46.9% 186.6 120.4 0.0 –31.2 NM NM NM NM NM NM Median 51.6% $397.3 $285.0 $6.0 –$50.7 1.6x NM 1.7x 11.4x NM 6.4x ($U.S. millions, except stock price) LTM Forward Forward EV Revenue EBITDA Stock % Below Multiples Multiples Multiples Price 52-Week Market Enterprise LTM LTM Company Ticker 11/30/17 High Value Value (EV) Revenue EBITDA Revenue EBITDA 2018 2019 2018 2019 22nd Century Group, Inc. AMEX:XXII $2.33 33.4% $287.9 $273.2 $14.0 –$11.3 19.5x NM 12.7x 10.7x NM NM India Globalization Capital, Inc. AMEX:IGC 0.58 27.6% 16.3 18.2 0.6 –1.6 28.8 NM NA NA NA NA Innovative Industrial Properties, Inc. New York Stock Exchange and NYSE American NYSE:IIPR 18.15 11.5% 63.5 41.3 4.6 –1.2 9.0 NM 2.4 1.3 3.7x 1.6x Median 27.6% $63.5 $41.3 $4.6 –$1.6 19.5x NM 7.6x 6.0x 3.7x 1.6x Ancillary Constellation Brands, Inc. NYSE:STZ $217.59 4.2% $42,572.2 $51,393.3 $7,458.5 $2,709.3 6.9x 19.0x 6.7x 6.3x 18.3x 16.6x The Scotts Miracle-Gro Company NYSE:SMG 98.90 3.5% 5,689.7 6,969.0 2,642.1 500.0 2.6 13.9 2.5 2.4 12.9 12.0 Median 3.9% $24,131.0 $29,181.2 $5,050.3 $1,604.7 4.8x 16.5x 4.6x 4.3x 15.6x 14.3x Source: S&P Global Market Intelligence. Not Meaningful (NM) used for negative multiples, and for revenue multiples greater than 100.0x and EBITDA multiples greater than 50.0x. Not Available (NA) used for information that is not available. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization. 124 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VII Capital Markets for Cannabis Companies Over The Counter (Market Value Greater than $25 million) LTM ($U.S. millions, except stock price) Stock % Below EV Multiples Price 52-Week Market Enterprise LTM LTM Company Ticker 11/30/17 High Value Value (EV) Revenue EBITDA Revenue EBITDA Abattis Bioceuticals Corp. OTCQB:ATTBF $0.22 20.2% $39.5 $38.8 $0.0 –$3.6 NM NM American Cannabis Company, Inc. OTCQB:AMMJ 0.75 40.5% 38.6 36.7 2.9 0.3 12.7x NM AmeriCann, Inc. OTCQB:ACAN 2.03 63.1% 39.3 42.4 0.0 –1.8 NM NM Amfil Technologies, Inc. OTCPK:AMFE 0.15 36.1% 99.7 99.9 0.2 NA NM NM AXIM Biotechnologies, Inc. OTCQB:AXIM 7.02 64.6% 382.8 387.5 0.0 –2.9 NM NM Cannabics Pharmaceuticals Inc. OTCQB:CNBX 1.02 86.6% 120.7 117.3 0.0 –1.8 NM NM Cannabis Leaf, Inc. OTCPK:PCFP 0.97 61.2% 48.8 48.9 0.0 NA NM NM Cannabis Sativa, Inc. OTCQB:CBDS 3.95 58.4% 83.8 83.5 0.1 –6.4 NM NM Cannabis Science, Inc. OTCPK:CBIS 0.06 56.3% 155.4 158.1 0.0 –9.6 NM NM Cannabix Technologies Inc. OTCPK:BLOZ.F 1.19 37.4% 103.0 100.5 0.0 NA NM NM CannaGrow Holdings, Inc OTCPK:CGRW 0.99 57.0% 100.3 102.7 1.7 –1.4 62.0 NM Corix Bioscience, Inc. OTCQB:CXBS 1.19 45.9% 29.6 29.6 0.0 NA NM NM Earth Science Tech, Inc. OTCPK:ETST 0.81 79.5% 32.0 31.9 0.4 NA 74.1 NM Evergreen-Agra Global OTCQB:EGRN 1.00 85.7% 26.4 26.4 0.0 –0.4 NM NM GB Sciences, Inc. OTCQB:GBLX 0.24 56.4% 31.3 37.0 0.2 –10.3 NM NM General Cannabis Corp. OTCQB:CANN 1.65 51.6% 37.1 39.5 0.1 –7.4 NM NM Green Spirit Industries Inc. OTCPK:GSRX 5.75 77.0% 172.6 172.6 0.0 NA NM NM GrowGeneration Corp. OTCQX:GRWG 2.50 13.8% 41.1 39.3 13.1 –1.2 3.0 NM Helix TCS, Inc. OTCPK:HLIX 3.00 76.9% 85.9 86.7 3.5 –3.0 24.9 NM HempTech Corporation OTCPK:HTCO 1.82 83.9% 100.7 101.7 0.0 –0.5 NM NM iAnthus Capital Holdings, Inc. OTCQB:ITHU.F 1.64 39.1% 61.7 74.3 0.1 NA NM NM Kush Bottles, Inc. OTCQB:KSHB 2.84 20.2% 170.4 170.2 18.8 0.8 9.1 NM Leafbuyer Technologies, Inc. OTCPK:LBUY 1.04 72.8% 39.9 39.8 0.9 NA 42.5 NM Lexaria Bioscience Corp. OTCQB:LXRP 0.82 18.8% 56.9 54.4 0.1 –1.8 NM NM Lifestyle Delivery Systems Inc OTCQB:LDSY.F 0.50 25.6% 46.0 44.6 0.7 –5.1 65.3 NM Marijuana Company of America OTCPK:MCOA 0.03 76.8% 54.6 55.0 0.0 –21.9 NM NM MariMed Inc. OTCQB:MRMD 0.70 16.3% 119.8 119.8 0.0 NA NM NM mCig, Inc. OTCQB:MCIG 0.17 66.1% 68.5 67.0 7.7 1.2 8.7 NM Medical Marijuana, Inc. OTCPK:MJNA 0.10 55.1% 307.1 317.7 8.0 –3.9 39.7 NM Medicine Man Technologies, Inc. OTCQB:MDCL 1.79 43.2% 39.2 39.0 2.4 –5.5 16.2 NM OWC Pharmaceutical Research OTCQB:OWCP 0.48 85.2% 70.1 69.0 0.1 –4.7 NM NM PharmaCyte Biotech, Inc. OTCQB:PMCB 0.05 71.6% 46.7 42.4 0.0 NA NM NM Player's Network, Inc. OTCQB:PNTV 0.08 66.1% 45.0 45.9 0.2 –4.7 NM NM Praetorian Property, Inc. OTCPK:PRRE 0.52 75.8% 81.1 93.5 14.1 NA 6.6 NM SanSal Wellness Holdings, Inc. OTCPK:SSWH 0.95 29.6% 55.9 57.4 0.6 –1.5 NM NM Stony Hill Corp. OTCPK:STNY 2.50 50.0% 39.0 38.8 0.2 NA NM NM Surna Inc. OTCQB:SRNA 0.15 35.5% 29.6 28.3 6.9 –3.3 4.1 NM Terra Tech Corp. OTCQX:TRTC 0.20 42.1% 178.2 173.6 31.9 –18.6 5.4 NM THC Therapeutics, Inc. OTCPK:THCT 0.34 60.6% 39.7 39.7 0.0 0.0 NM NM The Tinley Beverage Company OTCPK:QRSR.F 0.56 15.2% 41.4 38.8 0.1 NA NM NM United Cannabis Corporation OTCQB:CNAB 0.78 69.0% 46.7 46.0 0.5 NA 99.2 NM Vitality Biopharma, Inc. OTCQB:VBIO 1.85 56.4% 42.7 41.9 0.1 –4.3 NM NM WEED, Inc. OTCPK:BUDZ 2.79 44.8% 279.0 278.5 0.0 –5.2 NM NM WOWI, Inc. OTCPK:WOWU 1.65 67.0% 53.6 54.7 0.0 –26.0 NM NM Median 56.4% $54.1 $54.5 $0.1 –$3.4 16.2x NM © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 125 Cannabis Investment Report | December 2017 Comparison of U.S. Stock Markets U.S. stock markets vary significantly in terms of their financial, liquidity and corporate governance requirements. Most U.S. publicly traded cannabis-related companies trade on the OTC due to its less stringent requirements, as compared to Nasdaq and the NYSE. The following chart provides a comparison of Nasdaq, the NYSE and the OTC. U.S. Stock Market Comparison Nasdaq NYSE Nasdaq OTC Market Tiers Nasdaq Global Select Market Nasdaq Global Market Nasdaq Capital Market NYSE NYSE American OTCQX OTCQB OTCPink Number of Listed Companies Total Cannabisrelated 3,200+ 4 2,800+ 3 10,300+ 212 Market Value 1 Total Median $11.3 trillion $29.6 trillion $247.7 billion $334.0 million $1.5 billion $0.5 million Listing or Trading Requirements Must meet financial and liquidity criteria under at least one category of Standards. Criteria include: Stockholders’ Equity, Market Capitalization, Operating History, Net Income, Amount of Publicly Held Shares and Number of Shareholders. Must meet financial and liquidity criteria under at least one category of Standards. Criteria include: Stockholders’ Equity, Market Capitalization, Pre-tax Income, Amount of Publicly Held Shares and Number of Shareholders. OTCQX: Must meet minimum financial and liquidity criteria OTCQB and OTCPink: No financial and liquidity criteria Minimum Share Price Nasdaq Global Select Market: $4.00 Nasdaq Global Market: $4.00 Nasdaq Capital Market: $2.00 NYSE: $4.00 NYSE American: $2.00 OTCQX: $0.10 OTCQB: $0.01 OTCPink: None Corporate Governance Requirements • Annual audit • Audit committee and compensation committee • Majority of independent directors • Annual audit • Audit committee and compensation committee • Majority of independent directors OTCQX and OTCQB: • Annual audit • Audit committee • Two independent directors OTCPink: No requirements Reporting Requirements Required to file quarterly and annual reports Required to file quarterly and annual reports Not required to make regular filings Registration Requirements Required to register with the SEC Required to register with the SEC Not required to register with the SEC 1 Source: S&P Global Market Intelligence 126 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VII Capital Markets for Cannabis Companies n Public Capital Markets: Canada As of November 30, 2017, six cannabis-related companies were trading on the TSX, 20 were trading on the TSXV and 41 were trading on the CSE. Most of the publicly traded cannabis-related companies in Canada are licensed producers under Canada’s Access to Cannabis for Medical Purposes Regulations, which allow a company to produce and sell medical cannabis products in Canada. A number of companies traded on the CSE also have cannabis-related operations in the United States. The following table provides a summary of cannabis-related companies traded on Canadian stock markets. Summary of Canadian Publicly Traded Cannabis-Related Companies (As of November 30, 2017) Average ($U.S. millions) Number of Market Enterprise LTM LTM Companies Value Value Cash Debt Revenue EBITDA Toronto Stock Exchange (TSX) 6 $1,361.5 $1,311.4 $71.0 $20.8 $26.6 $0.8 TSX Venture Exchange (TSXV) 20 131.5 123.9 10.8 3.3 1.2 –3.5 Canadian Securities Exchange (CSE) 41 72.6 72.0 2.0 1.4 1.8 –2.8 Canada 67 $210.6 $203.3 $11.1 $3.8 $4.0 –$2.2 Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined by S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization. Stock Price Performance of Canadian Publicly Traded Cannabis-Related Companies The following chart shows the stock price performance of selected publicly traded cannabis-related companies in Canada since September 30, 2016. The chart indicates that the stock price performance of cannabis-related companies trading on Canadian markets received a boost from the announcement of the proposed recreational cannabis legislation in Canada by Prime Minister Justin Trudeau and, more recently, from Constellation Brands’ investment in Canopy Growth. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 127 Cannabis Investment Report | December 2017 Canadian Cannabis Stock Price Performance 1500% 1300% 1100% 900% 700% 500% Canadian Prime Minister announces plans to legalize recreational cannabis Constellation Brands’ investment in Canopy Growth 300% 100% –100% Sep 16 Nov 16 Jan 17 Mar 17 May 17 Jul 17 Sep 17 Nov 17 S&P/TSX Index Source: S&P Global Market Intelligence TSX/TSXV Cannabis Index CSE Cannabis Index Capital Raised by Canadian Publicly Traded Cannabis-Related Companies The following table shows the amount of capital (equity and debt) raised by cannabis-related companies traded on Canadian stock markets in the twelve months ended September 30, 2017. 128 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VII Capital Markets for Cannabis Companies Capital Raised by Canadian Publicly Traded Cannabis-Related Companies (LTM ended September 30, 2017) $1200 $1000 ($U.S. millions) $800 $600 $400 $200 $0 TSX TSXV CSE Total Amount Raised $403 $334 $319 $1056 Number of Deals 11 21 28 60 Average Deal Size $37 $16 $11 $18 Source: S&P Global Market Intelligence Financial Data and Trading Multiples of Canadian Publicly Traded Cannabis-Related Companies The following tables show selected financial and trading information of cannabis-related companies that are publicly traded on Canadian markets. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 129 Cannabis Investment Report | December 2017 Toronto Stock Exchange ($U.S. millions, except stock price) LTM Forward Forward EV Revenue EBITDA Stock % Below Multiples Multiples Multiples Price 52-Week Market Enterprise LTM LTM Company Ticker 11/30/17 High Value Value (EV) Revenue EBITDA Revenue EBITDA 2018 2019 2018 2019 Aphria Inc. TSX:APH $8.91 9.9% $1,350.2 $1,281.7 $17.7 $3.8 72.4x NM 37.7x 9.9x NM 27.5x Aurora Cannabis Inc. TSX:ACB 6.21 7.6% 2,483.5 2,406.8 18.6 –4.7 NM NM 48.6 13.6 NM 30.4 CanniMed Therapeutics Inc. TSX:CMED 15.15 10.9% 347.8 315.8 12.0 2.0 26.3 NM 10.6 5.4 48.5x 13.3 Canopy Growth Corporation TSX:WEED 14.30 15.1% 2,720.6 2,641.7 46.3 1.9 57.1 NM 39.7 11.7 NM NM MedReleaf Corp. TSX:LEAF 12.66 13.7% 1,146.2 1,094.8 32.9 9.7 33.3 NM 30.8 9.4 NM 27.0 Neptune Technologies & Bioressources Inc. TSX:NEPT 1.54 15.0% 120.8 127.4 32.4 3.7 3.9 NM 6.0 4.3 NM NM Median 12.3% $1,248.2 $1,188.3 $25.5 –$0.1 33.3x NM 34.2x 9.6x 48.5x 27.3x TSX Venture Exchange ($U.S. millions, except stock price) Stock Price % Below 52-Week Market Enterprise LTM LTM LTM EV Multiples Forward Revenue Multiples Forward EBITDA Multiples Company Ticker 11/30/17 High Value Value (EV) Revenue EBITDA Revenue EBITDA 2018 2019 2018 2019 ABcann Global Corporation TSXV:ABCN $1.13 19.9% $152.7 $129.7 $0.7 –$8.7 NM NM 11.2x 2.6x NM 9.2x Cannabis Wheaton Income TSXV:CBW 0.68 56.5% 157.2 157.0 0.1 –6.2 NM NM NA NA NA NA Cronos Group Inc. TSXV:MJN 3.38 9.0% 503.2 494.0 2.3 2.5 NM NM 16.1 5.8 NM 17.6 Delta 9 Cannabis Inc. TSXV:NINE 2.37 23.8% 143.9 145.5 0.4 –1.7 NM NM NA NA NA NA Emblem Corp. TSXV:EMC 1.26 64.6% 117.1 108.0 1.8 –7.5 59.4x NM 10.5 2.0 NA 5.6 Emerald Health Therapeutics TSXV:EMH 2.27 4.6% 213.8 195.6 0.6 –4.3 NM NM 46.6 NA NA NA Harvest One Cannabis Inc. TSXV:HVST 0.71 18.6% 63.7 54.1 0.2 –4.5 NM NM 17.0 1.8 NA 9.2 Hempco Food and Fiber Inc. TSXV:HEMP 1.66 31.6% 77.5 77.4 4.7 –1.3 16.5 NM NA NA NA NA ICC International Cannabis TSXV:ICC 0.76 44.3% 104.6 102.5 0.1 –4.5 NM NM 6.4 1.1 NM 4.0 Invictus MD Strategies Corp. TSXV:IMH 1.12 33.6% 89.6 66.7 1.8 –10.3 37.6 NM 27.3 3.6 NM 13.3 LGC Capital Ltd. TSXV:LG 0.29 24.0% 79.6 76.6 0.0 –1.7 NM NM NA NA NA NA Maple Leaf Green World Inc. TSXV:MGW 0.46 24.4% 67.3 64.2 0.4 –1.1 NM NM NA NA NA NA National Access Clinic Corp. TSXV:NAC 0.40 30.1% 24.0 25.0 0.7 –2.4 36.7 NM NA NA NA NA Naturally Splendid Enter. TSXV:NSP 0.21 45.0% 20.4 20.9 1.9 –4.3 10.9 NM NA NA NA NA Newstrike Resources Ltd. TSXV:HIP 0.39 16.7% 151.1 152.1 0.0 –0.3 NM NM NA NA NA NA OrganiGram Holdings Inc. TSXV:OGI 2.61 15.7% 277.4 244.2 4.0 –5.2 60.7 NM 9.7 3.4 46.5x 12.6 Tetra Bio-Pharma Inc. TSXV:TBP 0.54 14.8% 63.6 62.0 0.0 –3.9 NM NM NA NA NA NA The Hydropothecary Corp. TSXV:THCX 1.92 17.7% 149.8 133.3 3.3 –0.6 40.7 NM 15.8 3.6 NM 29.8 Viridium Pacific Group Ltd. TSXV:VIR 1.09 15.2% 49.5 48.6 0.0 –0.1 NM NM NA NA NA NA WeedMD Inc. TSXV:WMD 1.69 12.8% 123.2 121.0 0.5 –3.1 NM NM 9.9 2.3 NM 8.6 Median 21.8% $110.8 $105.3 $0.5 –$2.0 37.6x NM 13.5x 2.6x 46.5x 9.2x Source: S&P Global Market Intelligence. Not Meaningful (NM) used for negative multiples, and for revenue multiples greater than 100.0x and EBITDA multiples greater than 50.0x. Not Available (NA) used for information that is not available. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization. 130 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VII Capital Markets for Cannabis Companies Canadian Securities Exchange ($U.S. millions, except stock price) Company Ticker Stock Price 11/30/17 % Below 52-Week High Market Enterprise LTM LTM LTM EV Multiples Forward Revenue Multiples Forward EBITDA Multiples Value Value (EV) Revenue EBITDA Revenue EBITDA 2018 2019 2018 2019 Alliance Growers Corp. CSE:ACG $0.16 20.0% $6.9 $6.8 $0.0 $0.0 NM NM 5.0x 0.3x NM 0.8x Alternate Health Corp. CSE:AHG 1.52 78.0% 79.3 76.6 10.3 –6.4 7.4x NM NA NA NA NA Beleave Inc. CSE:BE 1.38 37.5% 44.8 44.1 0.0 –8.8 NM NM 11.4 NA NM NA Canada House Wellness Group Inc. CSE:CHV 0.29 43.3% 35.6 36.3 4.4 –4.1 8.2 NM NA NA NA NA CannaRoyalty Corp. CSE:CRZ 2.28 41.2% 96.9 96.3 2.2 –8.6 44.2 NM 3.1 1.8 17.0x 8.1 CannTrust Holdings Inc. CSE:TRST 5.43 12.5% 471.8 466.3 12.6 5.2 36.9 NM 9.0 5.5 31.8 20.6 DOJA Cannabis Company Limited CSE:DOJA 1.06 8.7% 16.2 16.0 0.0 –0.1 NM NM NA NA NA NA Eviana Health Corporation CSE:EHC 1.09 30.0% 16.7 17.2 0.0 0.0 NM NM NA NA NA NA Friday Night Inc. CSE:TGIF 0.39 13.8% 60.3 61.2 0.8 –1.9 74.3 NM NA NA NA NA Future Farm Technologies Inc. CSE:FFT 0.37 23.8% 37.2 37.7 0.3 –7.5 NM NM NA NA NA NA International Cannabrands Inc. CSE:JUJU.A 0.18 20.5% 1.8 2.4 0.2 –1.2 14.8 NM NA NA NA NA Global Cannabis Applications Corp. CSE:APP 0.26 20.9% 10.5 10.7 0.0 –1.1 NM NM NA NA NA NA Global Hemp Group Inc. CSE:GHG 0.09 17.2% 14.3 14.4 0.0 0.0 NM NM NA NA NA NA Golden Leaf Holdings Ltd. CSE:GLH 0.27 36.4% 110.1 115.5 7.9 –10.6 14.6 NM NA NA NA NA HealthSpace Data Systems Ltd. CSE:HS 0.08 23.1% 8.7 9.8 1.9 –1.5 5.1 NM NA NA NA NA High Hampton Holdings Corp. CSE:HC 0.30 22.0% 3.8 3.7 0.0 –0.3 NM NM NA NA NA NA InMed Pharmaceuticals Inc. CSE:IN 0.52 30.2% 67.5 62.7 0.0 –4.6 NM NM NA NA NA NA Isodiol International Inc. CSE:ISOL 1.14 18.8% 251.2 250.7 14.2 0.6 17.6 NM NA NA NA NA Kaneh Bosm BioTechnology Inc. CSE:KBB 0.06 37.5% 0.8 0.7 0.0 0.0 NM NM NA NA NA NA Liberty Health Sciences Inc. CSE:LHS 1.33 33.2% 377.5 377.5 0.0 0.0 NM NM NA NA NA NA Liberty Leaf Holdings Ltd. CSE:LIB 0.21 11.5% 20.2 19.7 0.0 –1.9 NM NM NA NA NA NA Lifestyle Delivery Systems Inc CSE: LDS 0.50 26.4% 46.0 44.6 0.7 –5.1 65.3 NM NA NA NA NA Lotus Ventures Inc. CSE:J 0.40 16.1% 17.8 17.7 0.0 –0.5 NM NM NA NA NA NA Marapharm Ventures Inc. CSE:MDM 0.76 44.6% 71.4 69.8 0.4 –3.6 NM NM NA NA NA NA Maricann Group Inc. CSE:MARI 1.76 15.9% 162.7 162.2 3.1 –14.3 52.9 NM 9.8 2.0 NM 5.8 Matica Enterprises Inc. CSE:MMJ 0.25 5.8% 57.1 56.0 0.0 –1.8 NM NM NA NA NA NA MPX Bioceutical Corporation CSE:MPX 0.39 51.5% 100.7 108.0 10.6 –3.5 10.2 NM 5.2 2.9 NM 12.3 MYM Nutraceuticals Inc. CSE:MYM 2.15 7.7% 200.8 200.4 0.3 –0.9 NM NM NA NA NA NA Platinex Inc. CSE:PTX 0.10 28.9% 9.9 9.8 0.0 –0.7 NM NM NA NA NA NA PUF Ventures Inc. CSE:PUF 0.79 11.3% 41.2 39.6 0.0 –1.2 NM NM NA NA NA NA Quadron Cannatech Corporation CSE:QCC 0.19 44.4% 10.7 10.0 1.7 –0.7 6.0 NM NA NA NA NA Quinsam Capital Corporation CSE:QCA 0.34 24.1% 15.0 12.8 0.0 0.1 NM NM NA NA NA NA Ravenquest Biomed Inc. CSE:RVT 0.03 47.1% 1.0 1.1 0.0 –0.2 NM NM NA NA NA NA Supreme Pharmaceuticals Inc. CSE:SL 1.06 33.2% 219.3 202.5 1.2 –13.4 NM NM 16.6 2.5 NM 7.8 TerrAscend Corp. CSE:TER 1.33 13.6% 61.9 61.0 0.0 –4.3 NM NM NA NA NA NA THC Biomed Intl Ltd. CSE:THC 0.59 33.9% 65.4 66.8 0.0 –1.2 NM NM NA NA NA NA True Leaf Medicine International Ltd. CSE:MJ 0.69 9.2% 46.4 45.9 0.8 –2.4 56.9 NM NA NA NA NA Valens Groworks Corp. CSE:VGW 0.85 33.9% 52.0 51.8 0.0 –3.4 NM NM NA NA NA NA Veritas Pharma Inc. CSE:VRT 0.69 5.3% 28.5 27.8 0.0 –2.4 NM NM NA NA NA NA Vodis Pharmaceuticals Inc. CSE:VP 0.30 61.0% 9.2 10.7 0.0 –3.6 NM NM NA NA NA NA Wildflower Marijuana Inc. CSE:SUN 0.52 46.0% 27.5 27.4 0.2 –0.8 NM NM NA NA NA NA Median 24.1% $41.2 $39.6 $0.0 –$1.5 16.2x NM 9.0x 2.2x 24.4x 8.0x © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 131 Cannabis Investment Report | December 2017 Comparison of Canadian Stock Markets Similar to stock markets in the United States, Canadian stock markets vary significantly in terms of their financial, liquidity and corporate governance requirements. Most Canadian publicly traded cannabis-related companies trade on the CSE due to its less stringent requirements, as compared to the TSX and TSXV. More than 10% of the companies traded on the CSE are cannabis-related companies. The following chart provides a comparison of the TSX, TSXV and CSE. Canadian Stock Market Comparison Toronto Stock Exchange (TSX) TSX Venture Exchange (TSXV) Canadian Securities Exchange Nasdaq (CSE) Number of Listed Companies Total Cannabisrelated 1487 6 1791 20 337 41 Market Value 1 Total ($U.S.) Median ($U.S.) $2.0 trillion $33.7 billion $6.2 billion $282.6 million $5.0 million $6.1 million Listing or Trading Requirements Must meet financial and liquidity criteria determined by a company’s industry.Criteria include: Earnings, Revenue, Cash Flow, Net Tangible Assets, Adequate Working Capital, Cash, Market Capitalization, Amount of Publicly Held Shares and Number of Shareholders. Must meet financial and liquidity criteria determined by a company’s industry.Criteria include: Net Tangible Assets, Revenue, Adequate Working Capital, Property, Operating History, Amount of Publicly Held Shares and Number of Shareholders. Must meet financial and liquidity criteria determined by a company’s industry and whether the company is an operating company. Criteria include: Revenue, Assets, Amount of Publicly Held Shares and Number of Shareholders. Corporate Governance Requirements • Annual audit • Audit committee • Two independent directors • Annual audit • Audit committee • Two independent directors • Annual audit • Audit committee Reporting Requirements Required to file quarterly and annual reports Required to file quarterly and annual reports Required to file quarterly and annual reports 1 Source: S&P Global Market Intelligence 132 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VII Capital Markets for Cannabis Companies n Private Capital Markets The cannabis industry today is replete with early-stage private companies seeking to raise capital. This capital, whether equity or debt, may be available from (i) “friends and family,” (ii) more formalized groups and networks of “angel” investors, (iii) family offices, (iv) dedicated cannabis investment funds (currently few in number, but growing), and (v) strategic investors. However, because of the legal considerations, traditional institutional investors—most notably the venture capital and private equity communities—continue to be mostly absent from the market. As with most early-stage companies in other industries, many emerging cannabis-related companies are trying to follow the typical progression of raising equity capital, as illustrated in the following chart. Equity Financing Progression for Cannabis-Related Companies Today Future Friends and Family Seed Series A Series B Series C Initial Public O�ering Individual Investors Institutional and Strategic Investors The following table provides a summary of the reported capital (equity and debt) raised by private cannabis-related companies in 2016 and year to date through November 30, 2017. While the table indicates that significant capital is available in the private markets, we believe that the dearth of acces - sible institutional capital makes it challenging for many companies to raise subsequent rounds of financing after successfully securing their start-up capital. In addition, the amount raised per transaction is small and there have been very few announced financings of meaningful size by private companies. While we believe that the data is informative, it is challenging to get accurate and comprehensive data for the number and dollar amount of transactions that occur in private markets within the cannabis industry because of the number of transactions that are not reported. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 133 Cannabis Investment Report | December 2017 Total Capital Raised by Private Cannabis-Related Companies Globally $600 $500 ($U.S. millions) $400 $300 $200 $100 $0 2016 2017 YTD Amount Raised Number of Deals Average Deal Size Source: Ackrell Capital $256 65 $4 $483 102 $5 The following table shows the scarcity of large transactions announced by private cannabis-related companies for the year to date through November 30, 2017. Selected Financings by Private Cannabis-Related Companies (YTD through November 30, 2017) ($U.S. millions) Issuer Amount Date düber Technologies Inc. $50.0 September 2017 Eaze Solutions, Inc. 27.0 September 2017 Surterra Holdings LLC 13.4 September 2017 Teewinot Life Sciences Corporation 12.3 April 2017 Hound Labs, Inc. 8.1 May 2017 iUNU, Inc. 6.3 August 2017 Green Leaf Medical, LLC 5.9 June 2017 RX Green Solutions LLC 5.3 July 2017 River Collective 5.0 April 2017 Greene Fox Enterprises 5.0 May 2017 134 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VII Capital Markets for Cannabis Companies In addition, an increasing number of direct lenders are participating in the private debt markets for cannabis-related companies. These lenders represent an important capital source for the industry, as typical forms of debt capital, such as bank financing, remain unavailable to most companies. As in other industries, debt financing is typically available only to those companies having meaningful cash flow or tangible assets to secure the debt. While the number of lenders is increasing, there is still a relative scarcity of debt capital available to the cannabis industry, which can lead to a higher debt cost of capital of 200–500 basis points or more for cannabis-related companies, as compared to companies in other industries. The following chart illustrates the type of debt that may be available to cannabis-related companies, representative terms of such debt, and the types of companies that may be able to access debt in the private markets. Debt Financing Alternatives for Cannabis-Related Companies Cost of Capital Covenants Senior Debt Lease Financing Subordinated Debt Low Double Digits Mid-teens More Restrictive � Type of Securitization (if secured): Land Buildings Equipment A/R Inventory � Type of Borrowers: Cultivators Extractors Dispensaries Product Manufacturers Convertible Debt High-teens to 20%+ Less Restrictive n Final Thoughts As stated previously, valuations and stock price fluctuations in the cannabis industry continue to be driven more by expectations for the cannabis industry in general than by individual company fundamentals. Today, in the public markets, trading volumes are too low, trading prices are too volatile and operating histories are too limited to place any reliance on current valuation levels in the cannabis industry. We believe that this dynamic will continue until cannabis-related companies have matured and start to realize meaningful revenue, profitability and other financial metrics that will allow investors to evaluate companies within the industry by more traditional methodology. It is still too early to know how the cannabis industry or its sectors will be valued in the future. It may come to pass that companies in the cannabis industry are valued comparably to public companies in industries with similar characteristics, such as the alcohol, tobacco, pharmaceutical and consumer © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 135 Cannabis Investment Report | December 2017 products industries, especially as companies from those industries look to enter the cannabis industry, through acquisition or by other means. As demonstrated by the more than $2.0 billion raised by publicly traded and private cannabisrelated companies in 2017, capital continues to be available to support the growth of the industry. In the public markets, we believe that Canadian stock markets will continue to be the most receptive globally (until more progress is made in the United States toward federal legalization of cannabis). Overview of Canadian and U.S. Stock Markets Canada United States Toronto Stock Exchange (TSX) TSX Venture Exchange (TSXV) Canadian Securities Exchange (CSE) Nasdaq/NYSE OTC Summary Largest exchange in Canada and one of world’s largest Affiliate of the TSX for smaller capitalization companies Perceived as the “OTC” of the Canadian markets by many investors Largest and most recognized stock exchanges in the world Negative reputation with many investors and regulators Benefits High volume of trading and liquidity; brand recognition; strong institutional support Possible uplisting to the TSX; better brand than the CSE Receptive to companies with U.S. cannabis operations; very few listing requirements High volume of trading and liquidity; brand recognition; strong institutional support Possible uplisting to other markets; very few requirements to trade Issues Not receptive to companies that violate U.S. federal law Not receptive to companies that violate U.S. federal law; limited liquidity for small issues Limited trading volume and liquidity; significant price fluctuations; limited institutional support Stringent listing requirements Limited trading volume and liquidity; significant price fluctuations; limited institutional support Outlook Expected to continue to attract the largest Canadian companies in the cannabis industry Viable exchange for smaller Canadian companies with no cannabis operations in the United States Viable exchange for smaller Canadian companies with cannabis operations in the United States With few exceptions, cannabis companies will not be able to list while federal prohibition continues Cannabis companies will continue to trade on the OTC despite the limited benefits Although capital continues to be available for select issuers in both the public and private markets, we believe that the cannabis industry will continue to face a large funding gap for the foreseeable future, driven by the lack of institutional investors. However, we believe a growing number of retail, institutional and family office investors will support the industry in 2018 and beyond. 136 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 In this chapter, we present our current list of the Top 100 Private Cannabis Companies. Our determination to include companies on the list is subjective, and the list is intended to be a cross-section of the types of companies in the cannabis industry. Our list comprises privately held companies, primarily U.S. companies, companies we believe have a strong reputation or position in their market segments and companies pursuing a line of business we consider promising. We intend to update our list periodically, and we expect it may change significantly over time. Most companies on our list are in early stages of development, and many will need to raise capital to succeed. Raising capital for early-stage companies in any industry is extremely challenging. Early-stage cannabis companies seeking capital face the same challenges as early-stage companies in other industries but must also address challenges unique to the cannabis industry. Although we hope the companies on our list ultimately succeed, we expect some will go out of business for any number of reasons, including lack of access to capital. Inclusion in our list does not represent an investment recommendation or endorsement of any particular company or product. We have made investments in and conducted investment banking and other services for companies included in the Top 100 Private Cannabis Companies 2018 list, and may do so in the future. Readers should be aware that we may have a conflict of interest that could affect the objectivity of our decision to include a company in the list. For additional disclosures and disclaimers, see page 175. © 2017Ackrell Capital, LLC | Member FINRA / SIPC 137 Cannabis Investment Report | December 2017 Top 100 Private Cannabis Companies 2018 AEssenseGrows Défoncé Jetty Extracts River Collective Ample Organics Dixie Elixirs Kikoko Rubicon Organics Apeks Supercritical Dosist KIVA Confections S2S Development The Apothecarium Eaze Solutions Korova SC Laboratories Auntie Dolores Eel River Organics LeafLink Scrubbed Baker Technologies Elemental Wellness Leafly SPARC BAS Research Euflora Level Blends Spectrum King BDS Analytics Evolve Therapeutics LivWell Enlightened Health Steep Hill Labs Beboe Evoxe Laboratories Lunchbox Alchemy StickyGuide Berkeley Patients Group Flow Kana Mary's Medicinals Strainz BioTrackTHC Flowhub Meadow Teewinot Life Sciences Bloom Farms FunkSac Merry Jane Tikun Olam Brewbudz Garden State Dispensary MiNDFUL Treez Bud and Bloom GFarmaLabs MJ Freeway Trellis Calyx Brands Gold Coast Extracts MJardin Trulieve Cannabis Reports Green Dot Labs MM Acquisition Co. Utopia Farms CannaCraft Green Flower Media Native Roots VapeWorld CannaKorp Green Rush New Vansterdam Vapexhale Colorado Harvest Company The Green Solution Northwest Cannabis Solutions VCC Brands Columbia Care Harborside Health Center NWT Holdings (Firefly) Vuber Confident Cannabis Harvest Organa Brands Wana Brands Cultivation Technologies Headset PAX Labs Web Joint Cura Cannabis Solutions HelloMD PharmaCielo Weedguide CW Analytical Humboldt Legends PRØHBTD Media Weedmaps Deep Cell Incense Specialties Qind Wellness Connection of Maine 138 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 AEssenseGrows Sunnyvale, California www.aessensegrows.com AEssenseGrows is a producer of modular aeroponic systems for cannabis cultivation. The company develops full-scale cultivation systems equipped with software, automation and monitoring capabilities. Such systems enable cultivators to deliver nutrients to the plant more efficiently, and thus generate higher-yielding output than conventional cultivation systems. Ample Organics Toronto, Ontario www.ampleorganics.com Ample Organics is a software developer for cannabis cultivators. The company offers a system to track all aspects of the cannabis cultivation business. The company’s products enable medical cannabis producers in Canada to comply with Canadian law. Apeks Supercritical Johnstown, Ohio www.apekssupercritical.com Apeks Supercritical is a provider of botanical oil extraction systems that utilize subcritical and supercritical CO 2 gas as a solvent. The company’s fully automated systems range from a 1-liter benchtop system to a 40-liter production system. These systems provide consistent extraction results for the production of cannabis concentrates. The Apothecarium San Francisco, California www.apothecarium.com The Apothecarium is an operator of recreational and medicinal cannabis dispensaries. The company offers cannabis flower, concentrates, edibles and accessories throughout its locations in California and Nevada. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 139 Cannabis Investment Report | December 2017 Auntie Dolores Oakland, California www.auntiedolores.com Auntie Dolores is a producer of branded cannabis-infused edibles. The company produces a variety of edibles, including pretzels, biscuits, brownies, cookies, corn and nuts. The company’s products are sold directly to cannabis consumers and through cannabis dispensaries in California. Baker Technologies Denver, Colorado www.trybaker.com Baker Technologies provides a customer relationship management platform for cannabis dispensaries and brands. The company provides messaging, loyalty programs and online ordering features to enable cannabis dispensaries to attract and retain cannabis consumers. BAS Research Berkeley, California www.basresearch.com BAS Research is a cannabis research and manufacturing company. The company provides its clients with bulk cannabis oil, cannabis-oil extraction consulting services, contract manufacturing and fulfillment. BDS Analytics Boulder, Colorado www.bdsanalytics.com BDS Analytics is a provider of data analytics solutions to the cannabis industry. The company tracks data from point-of-sale systems to provide insight into consumer buying patterns. The company sells its solutions to a wide range of customers. 140 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Beboe Los Angeles, California www.beboe.com Beboe is a producer of branded cannabis products. The company’s cannabis oil vaporizers and cannabis-infused edibles are available in dispensaries throughout California. Berkeley Patients Group Berkeley, California www.mybpg.com Berkeley Patients Group is an operator of a cannabis dispensary. The company retails a broad variety of cannabis products, including flower, pre-rolls, concentrates, edibles, topicals, seeds and accessories. It also operates an online e-commerce portal and offers a limited sameday delivery service to patients in Berkeley, California and the surrounding area. BioTrackTHC Ft. Lauderdale, Florida www.biotrack.com BioTrackTHC is a provider of compliance and business management software for the retail cannabis industry. The company’s software platform is designed for inventory and sales management to track the seed-to-sale process and is used by recreational and medicinal dispensaries, cultivators and state governments. Bloom Farms San Francisco, California www.getbloomfarms.com Bloom Farms is a producer of branded cannabis products, including cannabis oil and flower. The company’s products are available in dispensaries throughout California. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 141 Cannabis Investment Report | December 2017 Brewbudz San Diego, California www.brewbudz.us Brewbudz is a manufacturer of branded cannabis-infused products. The company develops cannabis-infused coffee, tea and cocoa pods that can be used in Keurig ® systems. Its products are available in select dispensaries in Nevada. Bud and Bloom Santa Ana, California www.budandbloomoc.com Bud and Bloom is the operator of a cannabis dispensary. The company offers cannabis flower, concentrates, edibles and accessories and sells these products at its Santa Ana location. Calyx Brands Oakland, California www.gocalyx.com Calyx Brands is a cannabis distribution company. The company engages in the distribution, transportation and marketing of cannabis products. Cannabis Reports Berkeley, California www.cannabisreports.com Cannabis Reports is a publisher of industry data for cannabis users and business owners. The company offers news, studies, product information and dispensary information. 142 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 CannaCraft Santa Rosa, California www.cannacraft.com CannaCraft is a producer of branded strainspecific cannabis concentrates and cannabisinfused edibles. The company provides a range of high-THC products, including concentrate cartridges, oils, softgels, sprays and straws. It focuses on providing concentrates of the most popular cannabis flower strains. Products are sold through cannabis dispensaries in California. The company manufactures its products under the AbsoluteXtracts, Care By Design and Satori brands. CannaKorp Boston, Massachusetts www.cannakorp.com CannaKorp is a manufacturer of branded cannabis consumer products. The company produces the CannaCloud, a tabletop vaporizer system utilizing single-use cannabis-infused pods. Colorado Harvest Company Denver, Colorado www.coloradoharvestcompany.com Colorado Harvest Company is an operator of recreational and medicinal cannabis dispensaries and cultivation facilities. The company’s three dispensary locations retail flower, concentrates and edibles. It also operates an indoor hydroponic grow facility. Columbia Care New York, New York www.col-care.com Columbia Care is an operator of medical cannabis dispensaries and cultivation facilities. The company operates 27 medical dispensaries across 9 states and the District of Columbia under several brands, including Columbia Care, Curative Health, Patriot Care and SWC Arizona. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 143 Cannabis Investment Report | December 2017 Confident Cannabis Palo Alto, California www.confidentcannabis.com Confident Cannabis is a cannabis lab-testing and analytics company. The company allows users to view the results of their product testing and analytics in an online platform. Its technology can be integrated into dispensary websites. Cultivation Technologies Coachella, CA www.cultivationtech.com Cultivation Technologies provides infrastructure, genetics, technology and branding to the legal cannabis industry. The company is building a campus for the development of pharmaceutical-grade cannabis products. Cura Cannabis Solutions Portland, Oregon www.curacan.com Cura Cannabis Solutions is a provider of cannabis concentrates. The company offers cannabis distillates and oils to consumers and edibles manufacturers. Its products are available in dispensaries throughout California, Nevada and Oregon. CW Analytical Oakland, California www.cwanalytical.com CW Analytical is a cannabis lab-testing company that tests cannabis and cannabis-based products for potency, pesticides and microbiology. The company also consults with dispensaries and edibles manufacturers to provide best practices for product handling and product labeling. 144 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Deep Cell Seattle, Washington www.deepcell.industries Deep Cell is a synthetic biology and cannabis intellectual property holding company. The company provides licenses to companies who wish to produce Deep Cell’s cannabis-infused sugar. Its products are available from Deep Cell licensees. Défoncé Oakland, California www.defonce.com Défoncé is a producer of branded cannabisinfused products, primarily focusing on chocolate-based edibles. The company offers a wide range of chocolate-bar flavors that are available in dispensaries located throughout California. Dixie Elixirs Denver, Colorado www.dixieelixirs.com Dixie Elixirs is a producer of branded cannabis-infused edibles. The company produces a wide range of products, including chocolate-based edibles, beverages, capsules, mints, energy shots, topicals and disposable vaporizer pens. The company’s products are sold in many dispensaries throughout California and Colorado. Dosist Los Angeles, California www.dosist.com Dosist is a producer of cannabis vapor izers. The company develops pre-filled cannabis vaporizers that are designed to provide consumers with a specific mood. The company’s products are available in dispensaries located throughout California. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 145 Cannabis Investment Report | December 2017 Eaze Solutions San Francisco, California www.eaze.com Eaze Solutions is a developer and provider of an on-demand cannabis delivery-service application that enables consumers to order cannabis products via mobile devices. The company’s mobile application allows users to access a daily menu of cannabis products for purchase and direct-to-consumer delivery. Eel River Organics Sacramento, California www.eelriverfamilyfarm.com Eel River Organics is a producer of branded cannabis products from Humboldt County, California. The company offers can nabis flower, concentrates, vaporizer cartridges and cultivation equipment. Its products are available in select California dispensaries. Elemental Wellness San Jose, California www.elementalwellnesscenter.com Elemental Wellness is an operator of a cannabis dispensary and wellness center in San Jose, California. The company offers a range of cannabis flower, concentrates and edibles, as well as delivery services and a range of wellness classes. Euflora Denver, Colorado www.eufloracolorado.com Euflora is an operator of four recreational cannabis dispensaries in Colorado. The company’s locations sell flower, pre-rolls, concentrates, topicals, seeds, vaporitzers and branded accssories. The company also cultivates numerous cannabis strains in its own grow facility. 146 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Evolve Therapeutics San Francisco, California www.evolvetherapeutics.com Evolve Therapeutics is a biopharmaceutical company focused on the research and manufacture of cannabinoid-based medications. The company produces a variety of cannabis products that are available in dispensaries located throughout California. Evoxe Laboratories Oakland, California www.evoxelabs.com Evoxe Laboratories is a producer of cannabis vaporizers. The company develops pre-filled cannabis vaporizers that are designed to provide consumers with a specific mood. The company’s products are available in dispensaries throughout California. Flow Kana San Francisco, California www.flowkana.com Flow Kana is a producer of cannabis flower. The company owns property in Mendocino County, where it plans to partner with small cultivators to create an institute for cannabis manufacturing, education and leisure. Flowhub Denver, Colorado www.flowhub.co Flowhub is a provider of inventory management software for the cannabis industry. The company provides software to aid cultivators and dispensary operators in tracking their business from seed to sale. The software is designed to aid customers in compliance. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 147 Cannabis Investment Report | December 2017 FunkSac Denver, Colorado www.funksac.com FunkSac is a provider of compliant packaging solutions for the medicinal and recreational cannabis industry. The company has a comprehensive product line manufactured with FDA-approved material and eco-friendly cannabis packaging solutions that are highly secure. FunkSac retails its products to cultivators, dispensaries and edibles manufacturers. Garden State Dispensary Woodbridge, New Jersey www.gardenstatedispensary.com Garden State Dispensary is a medicinal cannabis dispensary located in New Jersey. The company produces its own medical cannabis and offers a patient research and counseling program. GFarmaLabs Anaheim, California www.gfarmalabs.com GFarmaLabs is a producer of branded cannabis, cannabis-infused edibles, cannabis concentrates and vaporizer accessories. The company produces pre-rolls, beverages, chocolate-based edibles, honey, concentrate cartridges and injectors. GFarmaLabs sells its products through dispensaries in California and Washington. Its products are marketed as being produced from “100% indoor flower.” Gold Coast Extracts Los Angeles, California www.goldcoastusa.com Gold Coast Extracts is an extraction consultant and producer of branded cannabis concentrates. The company provides extraction consulting services to cultivators and concentrates producers. It also produces an award-winning line of branded cannabis concentrates in shatter and wax form. The company’s products are sold in dispensaries throughout California. 148 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Green Dot Labs Boulder, Colorado www.greendotlabs.com Green Dot Labs is a cultivation and extrac tion company that provides branded concentrates to consumers. The company operates an indoor hydrocarbon extraction facility and utilizes proprietary cannabis-flower genetics to produce whole-plant extracts. The company’s products are available in dispensaries throughout Colorado. Green Flower Media Ventura, California www.learngreenflower.com Green Flower Media is a digital media company operating a website that offers cannabis industry information. The company offers on line classes to customers who are interested in learning about all things cannabis-related. The com pany’s website also offers informational live streams from industry professionals. Green Rush San Mateo, California www.greenrush.com Green Rush provides an online medical cannabis delivery service. The company offers a range of cannabis flower, concentrates, edibles, tinctures and accessories. It has partnered with hundreds of cannabis dispensaries in California, Colorado, Nevada, New York and Michigan. The Green Solution Denver, Colorado www.tgscolorado.com The Green Solution is an operator of medicinal and recreational cannabis dispensaries. The company’s 15 locations retail flower, pre-rolls, concentrates, edibles, topicals, seeds, vaporizers and branded accessories. The company also produces its own line of branded concentrates and edibles. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 149 Cannabis Investment Report | December 2017 Harborside Health Center Oakland, California www.shopharborside.com Harborside Health Center operates cannabis dispensaries. The company’s two locations retail flower, pre-rolls, concentrates, edibles, seeds, topicals and accessories. The company sources cannabis-flower products from local cultivators. Harvest San Francisco, California www.harvestshop.com Harvest is an operator of cannabis dispensaries. In addition to offering a full range of cannabis products, the company’s dispensaries also serve as smoking lounges. The company has two locations in San Francisco. Headset Seattle, Washington www.headset.io Headset is a data analytics company for businesses within the cannabis industry. The company offers a SaaS product that tracks market data, business intelligence and retailer-direct data with clients located in states where cannabis has been legalized. HelloMD San Francisco, California www.hellomd.com HelloMD provides a digital healthcare platform. The company provides prescriptions for medicinal-cannabis patients via online, live video consultations. The company also provides a dispensary locator and cannabis product reviews. 150 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Humboldt Legends Trinidad, California www.humboldtlegends.com Humboldt Legends is a producer of cannabis flower products sourced from Humboldt County, California. The company offers cannabis flower in eighths and pre-rolls. The company’s products are available in dispensaries throughout California. Incense Specialties Lake Worth, Florida www.thisthingrips.com Incense Specialties is a producer of cannabis vaporizers. The company designs and manufactures a line of vaporizer pens under the brand name “This Thing Rips.” The company’s products are available in more than 4,000 points of sale across the United States and Canada. Jetty Extracts Oakland, California www.jettyextracts.com Jetty Extracts is a producer of cannabis vaporizers and cannabis concentrates. The company develops pre-filled cannabis vaporizers, cartridges and wax that offer the consumer formulations of both THC and CBD. The company’s products are available in dispensaries throughout California. Kikoko San Francisco, California www.kikoko.com Kikoko is a producer of branded cannabisinfused teas. The company offers a range of THC and CBD teas. Kikoko products are available in select California dispensaries. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 151 Cannabis Investment Report | December 2017 KIVA Confections San Leandro, California www.kivaconfections.com KIVA Confections is a producer of branded cannabis-infused edibles. The company’s awardwinning products are sold through cannabis dispensaries in California and Colorado. Korova Oakland, California www.korovaedibles.com Korova is a producer of branded cannabisinfused edibles. The company offers a selection of cannabis-infused cookies and brownies at varying potencies. The company’s products are available in dispensaries located in California, Arizona and Nevada. LeafLink New York, New York www.leaflink.com LeafLink provides a software platform to facilitate e-commerce B2B sales, CRM and order fulfillment tracking of products for cannabis brands and dispensaries. Leafly Seattle, Washington www.leafly.com Leafly is a digital media company. Its online directory and content platform for cannabis consumers provides information about locations of dispensaries, news pertaining to the cannabis industry and the effects of different cannabis strains. 152 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Level Blends San Francisco, California www.levelblends.com Level Blends is a producer of branded cannabis concentrates. The company utilizes a proprietary extraction process to produce a line of branded concentrates for use in vaporizers. The company’s products are available in dispensaries throughout California. LivWell Enlightened Health Denver, Colorado www.livwell.com LivWell Enlightened Health is an operator of medicinal and recreational cannabis dispensaries and cultivation facilities. The company operates 15 retail locations in Colorado and Oregon and sells flower, pre-rolls, concentrates, edibles, topicals and branded accessories. It also operates an indoor cultivation facility and is recognized as the largest cannabissector employer in Colorado. Lunchbox Alchemy Bend, Oregon www.lunchboxalchemy.com Lunchbox Alchemy is a producer of branded cannabis-infused edibles and cannabis concentrates. The company produces cannabis-infused candies and macaroons, concentrate cartridges and ethanol tinctures. Its products are available in dispensaries throughout Oregon. Mary’s Medicinals Denver, CO www.marysmedicinals.com Mary’s Medicinals is a producer of branded cannabis concentrates. The company provides a range of transdermal patches and pens, topicals and powders featuring cannabinoid-based concentrates. The company’s award-winning products deliver cannabinoids, including THC and CBD as well as THCA, CBN and CBC. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 153 Cannabis Investment Report | December 2017 Meadow San Francisco, California www.getmeadow.com Meadow is a developer and provider of an on-demand cannabis delivery-service application for dispensaries. The company markets online and mobile-ordering applications for dispensaries. The web and mobile applications allow users to access a menu of can nabis products for purchase and direct-to-consumer delivery through dispensaries. Merry Jane Los Angeles, California www.merryjane.com Merry Jane is a digital media company focused on the cannabis industry. The company’s website provides commentary on recent events, pop culture, business, politics and health-related news. The company provides strain reviews and information, as well as a dispensary locator. MiNDFUL Denver, Colorado www.bemindful.today MiNDFUL is an operator of recreational and medicinal cannabis dispensaries. The company operates five retail locations in Colorado and a single location in Illinois. The company sells flower, concentrates, edibles, topicals and branded accessories. MJ Freeway Denver, Colorado www.mjfreeway.com MJ Freeway is a provider of enterprise management software for the cannabis industry. The company’s core solution is a software platform for inventory and sales management to track the seed-to-sale process in compliance with state requirements. The software is used by recreational and medicinal dispensaries, infused-product manufacturers and cultivators. 154 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 MJardin Denver, Colorado www.mjardin.com MJardin is a provider of cannabis cultivation management services. The company offers facility design, inventory tracking, and management and operational consulting services. The company’s services are available in states having medical or recreational laws. MM Acquisition Co. Los Angeles, California MM Acquisition Co. is a provider of turnkey real estate services and business services to cannabis cultivators and dispensary operators in California. The company operates in three business segments: Property Leasing Business, Services Business and Other Related Businesses. Native Roots Denver, Colorado www.nativeroots303.com Native Roots is an operator of medicinal and recreational cannabis dispensaries and cultivation facilities. The company operates 21 dispensaries and retails flower, pre-rolls, concentrates, edibles and vaporizer accessories. The company also sells a line of branded hash-oil concentrates under the “Native Roots Extracts” brand. It operates an indoor cultivation facility and has won numerous industry awards for the operation. New Vansterdam Vancouver, Washington www.newvansterdam.com New Vansterdam is an operator of a cannabis dispensary in Washington. The company offers a selection of cannabis flower, concentrates, edibles and topicals. It also offers online ordering. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 155 Cannabis Investment Report | December 2017 Northwest Cannabis Solutions Olympia, Washington www.nwcs425.com Northwest Cannabis Solutions is a manufacturer of white-label cannabis products. The company offers cannabis flower cultivation, extraction and infused edibles. It supplies dispensaries throughout Washington. NWT Holdings (Firefly) San Francisco, California www.thefirefly.com NWT Holdings is a vaporizer technology company. The company designs and manufactures branded convective-heating vaporizers under the “Firefly” brand. Its portable vaporizer is designed for use with concentrates and flower. Organa Brands Denver, Colorado www.organabrands.com Organa Brands is a manufacturer and distributor of cannabis products and vaporizers. The company manufactures and retails its products under the Organa Labs, O.penVAPE, Bakked, Magic Buzz and District Edibles brands. The company’s products are distributed through 1,200 dispensaries across ten states. PAX Labs San Francisco, California www.paxvapor.com PAX Labs is a vaporizer technology company that designs and manufactures branded vaporizers that use conductive heating. The company’s portable vaporizers are designed for use with concentrates and flower. 156 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 PharmaCielo Rionegro, Colombia www.pharmacielo.com PharmaCielo is an emerging global supplier of naturally grown and processed, standardized medicinal-grade cannabis extracts. The company holds the first cannabis-processing license issued under the legal framework of Colombia’s cannabis laws and has one of the largest cultivation platforms in the cannabis industry, with more than 14.6 million square feet of companyowned or contracted open-air greenhouses in Colombia, South America. PRØHBTD Media Los Angeles, California www.prohbtd.com PRØHBTD Media is a vertically integrated digital media company. The company provides digital agency services to cannabis brands, maintains a cannabis-related art, music, video, fashion, travel and lifestyle website and develops original media content focused on the cannabis industry. Qind San Francisco, California www.qind.com Qind is a producer and distributor of branded cannabis products, including flower, concentrates, edibles and other infused products. The company sells directly to consumers through in-home events, e-commerce and next-day home delivery. The company also provides educational materials and content to its customers through its social network. River Collective Sacramento, California www.rvrdc.com River Collective is a distribution company for branded cannabis products. The company partners with businesses throughout California that produce cannabis flower, concentrates and edibles. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 157 Cannabis Investment Report | December 2017 Rubicon Organics Bellingham, Washington www.rubiconorganics.com Rubicon Organics is a licensed cannabis cultivator specializing in the growing, processing, packaging and marketing of cannabis. The company is developing greenhouses in Washington and California. S2S Development San Francisco, California www.s2s-inc.com S2S Development is a contract manufacturer and distributor of cannabis products. The company provides manufacturing, co-packing, testing and distribution services to cannabis companies. SC Laboratories Santa Cruz, California www.sclabs.com SC Laboratories is a cannabis lab-testing company. The company tests cannabis and cannabisbased products for potency, pesticides and microbiology, adhering to FDA and other guidelines in its testing. The company also provides consulting services to cultivators, dispensaries and producers of cannabis-infused edibles to implement industry best practices. Scrubbed San Francisco, California www.scrubbed.net Scrubbed is an outsourced bookkeeping, accounting and tax firm serving the cannabis industry. The company has a dedicated cannabis practice that provides clients with comprehensive turnkey accounting and tax solutions. 158 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 SPARC San Francisco, California www.sparcsf.com SPARC operates three cannabis dispensaries. It also provides lab-testing services. In addition to the company’s dispensary locations, the company provides a direct-to-consumer delivery service for flower, pre-rolls, concentrates, edibles, seeds and accessories. The company performs in-house testing of its products and operates its own cultivation facility. Spectrum King Canoga Park, California www.spectrumkingled.com Spectrum King is a producer of cannabis grow lights and accessories. The company offers a range of full-spectrum LED grow lights and grow tents. Its products are available through a network of international distributors. Steep Hill Labs Berkeley, California www.steephill.com Steep Hill Labs is a cannabis lab-testing company that tests cannabis and cannabisbased products for potency, pesticides and microbiology. The company has developed QuantaCann2™, an in-field cannabis-testing technology system; GenKit™, a male cannabisplant identification system; and Strain Fingerprint™, a graphical depiction of a strain’s most common cannabinoids. The company has locations or licensees nationwide. StickyGuide Los Angeles, California www.stickyguide.com StickyGuide is a digital media company that operates an online content and directory site focused on cannabis consumers. The company’s website provides detailed cannabis-strain information as well as reviews. The company also provides a dispensary locator. The website maintains an active member base and an online user-generated content forum. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 159 Cannabis Investment Report | December 2017 Strainz Las Vegas, Nevada www.strainz.com Strainz is a cannabis-brand management company. The company partners with producers to create cannabis oil cartridges and tinctures. Its products are available in dispensaries located in Colorado, Nevada and Washington. Teewinot Life Sciences Tampa, Florida www.tlscorp.com Teewinot Life Sciences is a pharmaceutical company focused on the biosynthetic production of cannabinoids. The company has developed processes for cannabinoid formulations intended for cannabinoid-based human therapies. Tikun Olam Safed, Israel www.tikun-olam.info Tikun Olam produces and supplies cannabis in Israel. The company cultivates medical cannabis strains, conducts research and educates patients on the use of medical cannabis. It conducts business in Israel, Canada, Australia and the United States. Treez Fremont, California www.treez.io Treez is a software company that has developed an enterprise resource-management platform for cannabis dispensaries. The company provides software and services to support all aspects of operations in dispensaries located throughout a number of states. 160 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Trellis Oakland, California www.trellisgrows.com Trellis provides inventory-management software for the cannabis industry. The company provides software to aid cultivators, producers and dispensary operators in tracking their business from seed to sale. The software is designed to aid customers in compliance. Trulieve Quincy, Florida www.trulieve.com Trulieve is an operator of medical cannabis dispensaries in Florida, offering a selection of concentrates in the form of capsules, syringes, tinctures and vaporizers. The company also maintains its own cannabis cultivation facility. Utopia Farms Santa Cruz, California www.utopiafarms.org Utopia Farms is a producer of branded cannabis products. The company produces cannabis flower, concentrates and cannabisinfused macaroons that are available in dispensaries throughout California. VapeWorld Boca Raton, Florida www.vapeworld.com VapeWorld operates an online e-commerce website dedicated to cannabis accessories. Vaporizers from leading manufacturers, as well as parts and accessories, are available on its website. The company also provides consumers with online content about vaping. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 161 Cannabis Investment Report | December 2017 Vapexhale San Francisco, California www.vapexhale.com Vapexhale is a vaporizer technology company that designs and manufactures branded vaporizers that use conductive heating. The company develops tabletop and portable vaporizers that are designed for use with concentrates and flower. VCC Brands Los Angeles, California www.vccbrands.com VCC Brands is a manufacturer of branded cannabis-infused products. The company offers cannabis-infused beverages, cookies, chocolates, teas, honeys, cooking oils and tinctures. Its products are available in dispensaries located throughout California and Washington. Vuber Seattle, Washington www.vubervaporizers.com Vuber is a manufacturer of cannabis vaporizers. The company designs and markets cannabis vaporizers and vaporizer accessories that are available in retail stores and dispensaries in Washington and Oregon. The company’s products are also available online. Wana Brands Boulder, Colorado www.wanabrands.com Wana Brands is a producer of cannabis-infused products, including cannabis-infused candies and capsules. Its products are available in dispensaries in Colorado, Oregon and Nevada. 162 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER VIII Top 100 Private Cannabis Companies 2018 Web Joint Los Angeles, California www.webjoint.com Web Joint is an online technology softwareas-a-service company. The company provides software for dispensaries to manage point-ofsale transactions, online ordering and delivery management. The software integrates with a dispensary’s website for a white-labeled software solution. Weedguide San Diego, California www.weedguide.com Weedguide is a digital media company that operates a cannabis-centric search engine and an informational website about recreational and medical cannabis. The site offers a collection of articles, videos, products, dispensary locations, recipes and strain information. Weedmaps Orange County, California www.weedmaps.com Weedmaps is a digital media company that operates an online networking and content directory site. The company allows users to locate and view reviews of local cannabis dispensaries, as well as user-generated strain reviews. Wellness Connection of Maine Portland, Maine www.mainewellness.org Wellness Connection of Maine is an operator of medical cannabis dispensaries in Maine. The company offers a selection of cannabis flower, concentrates, edibles and recipes. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 163 CHAPTER IX Cannabis Industry Risk Factors Companies in the cannabis industry are subject to many risks. The realization of one or more of these risks could have a material adverse effect on the business and results of operations of a company and on its lenders, investors and principals. The following discussion highlights some, but not all, of these risks. Risks Related to U.S. Federal Law • The manufacture, distribution, dispensing and possession of cannabis are strictly controlled under the Controlled Substances Act (CSA), irrespective of whether such activities comply with applicable state law. Financial transactions in connection with cannabis-related violations of the CSA may violate other federal laws. Individuals and businesses—including the principals, employees, directors, agents, lenders and investors of such businesses—that violate the CSA or such other laws are subject to fines, asset seizure and imprisonment under federal law. • Federal statutes and policies that currently restrict or deprioritize enforcement of certain CSA violations related to cannabis are subject to expiration, rescission and other changes. There can be no assurance that in the future the federal government will not strictly and aggressively enforce cannabis-related CSA provisions. • If CSA controls applicable to cannabis are relaxed or repealed in the future, other federal laws and regulations governing the production, distribution and marketing of products for human consumption, such as the Federal Food, Drug, and Cosmetic Act, may be more strictly enforced by the federal government in relation to the cannabis industry. • CSA controls and federal enforcement priorities applicable to cannabis both preclude interstate commerce in cannabis and cannabis products. As a result, it can be costly or impractical for companies in the cannabis industry to operate in multiple states and to gain economies of scale through centralized operations. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 165 Cannabis Investment Report | December 2017 • Federal income tax law precludes a business that “consists of trafficking in” cannabis or cannabis products from deducting certain operating expenses in determining its federal income tax. As a result, businesses in the cannabis industry may have effective tax rates significantly higher than other businesses subject to federal income tax, may owe tax on taxable income that is not actual economic income generated by the business and may have tax liabilities in amounts that exceed cash reserves. • Because of CSA controls on cannabis and federal laws applicable to banks and other financial institutions, companies in the cannabis industry may not be able to open or maintain bank accounts or access products and services of traditional financial institutions, such as credit facilities, payment processing and insurance coverage. A lack of access to banking and other traditional financial products and services increases the time, effort and expense related to ongoing operations and increases risks associated with cash transactions and the use of alternative products and services. • Trademarks used by companies to identify, distinguish or indicate the source of cannabis or related products or services that are illegal under federal law are not eligible for registration under federal trademark law, which is generally recognized as the most comprehensive trademark protection available in the United States. Alternative means of protecting such trademarks may not be available or may provide protections inferior to the protection provided by federal registration. • Protections afforded under federal bankruptcy law generally are not available to companies whose assets consist of federally illegal cannabis products or proceeds therefrom or to the creditors of such companies. • The federal government may pursue legal action against a state related to the state’s cannabis laws, which may result in significant changes to the state’s legal landscape as it relates to cannabis and may materially and adversely affect cannabis businesses in the state. • Cannabis companies outside the United States whose business plans anticipate eventual access to U.S. markets face uncertainty as to the timing or nature of changes in federal law that would allow importation of cannabis products into the country. Risks Related to U.S. State and Local Laws • State laws and regulations that legalize or decriminalize cannabis and related activities are relatively new and may change significantly or be reversed. The extent and nature of any such changes are not foreseeable and may force cannabis companies to materially alter their business models, suffer material losses or cease operations entirely. • State and local laws may limit the number of cannabis businesses in the state or in a particular locality, restrict the nature of such businesses (for example, by prohibiting for-profit cannabis businesses) or place restrictions on the persons permitted to own or operate such businesses. • Many state and local jurisdictions support legalizing or decriminalizing cannabis activities primarily for the potential to generate tax revenue, and there is significant public pressure to impose a heavy tax burden on those participating in the cannabis industry. State and local governments may impose significant taxes on commercial cannabis activity and may do so unpredictably. 166 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER IX Cannabis Industry Risk Factors • There is currently a lack of broad interstate reciprocity with respect to cannabis laws. • Even in states where cannabis is legal under state law, local jurisdictions may impose bans or restrictions that materially interfere with or effectively prevent the operation of cannabis businesses within their boundaries. Risks Related to the Manufacture and Sale of Cannabis Products • Cannabis companies are exposed to various product liability claims associated with human consumption of cannabis products, including claims that products cause injury, illness, possible side effects or interactions with other substances, or that products include inadequate instructions for use or warnings concerning health risks. • Cannabis companies may be subject to product recalls for a variety of reasons, including product defects, such as contamination. Such recalls may result in financial burdens and reputational harm and may subject cannabis companies to increased regulatory scrutiny. • Consumer perception of cannabis products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention and other publicity regarding the consumption of cannabis. Any unfavorable developments in these areas could have a material adverse effect on the demand for cannabis products in general or on the products or prospects of a particular company. Risks Related to Early-Stage Cannabis Companies • Most cannabis companies are in early stages of development and have limited operational history, so it is difficult to accurately predict and forecast their business operations. Many cannabis companies will fail. • The success of many early-stage cannabis companies is premised on receiving and maintaining the licenses, permits and regulatory approvals required for their proposed cannabis activities. Many of such companies will not receive or maintain such licenses, permits and approvals or may be able to do so only at significant expense. • Cannabis companies’ access to the capital required to grow and to finance ongoing operations involves challenges particular to the industry’s uncertain and rapidly evolving legal landscape. Many early-stage companies in the cannabis industry will not be able to obtain the requisite capital or will run out of capital prior to reaching profitability. • Early-stage cannabis companies may experience unexpected problems in the areas of product development and quality, manufacturing, marketing and general management, which, in some cases, cannot be adequately solved. Companies may also be subject to product pricing and cost pressures and to claims of intellectual property infringement. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 167 Cannabis Investment Report | December 2017 Other Risks to Companies in the Cannabis Industry • The cannabis industry is extremely competitive in most segments, with certain companies having unique competitive advantages such as greater capital resources, first-mover advantage, more scalable business models and greater brand recognition. • To date, the research conducted on cannabinoid-derived pharmaceuticals and other cannabisbased therapies is limited. There is no assurance that cannabinoid-derived pharmaceuticals or other medi cal products will prove effective in treating medical conditions or achieve broad market acceptance. • Given the emerging nature of the cannabis industry, there is a scarcity of qualified personnel with deep industry experience and significant competition for such qualified personnel. Many cannabis companies may not be successful in attracting, training, integrating, motivating or retaining qualified management teams and other personnel. • Cannabis is an agricultural product. The occurrence of diseases, insects, pests, mold and other infestations and severe adverse environmental conditions, such as fire, drought, hail, flood or frost, is unpredictable, may have a potentially devastating impact on agricultural production of cannabis and may otherwise adversely affect the supply of cannabis. • The cannabis industry is particularly vulnerable to rapidly changing technology, government regu lation and relatively high risks of obsolescence caused by scientific and technological advances. The success of cannabis companies will depend in part on their ability to anticipate market, legal, technological and other trends in the industry. Many cannabis companies will fail to accurately identify or predict industry trends. • Cannabis laws and regulations in jurisdictions outside the United States vary widely and, in some cases, are as complex, contradictory and rapidly changing as those within the United States. Cannabis companies operating outside the country’s borders are subject to risks related to the unsettled legal environment applicable to cannabis. • Due to federal controls on cannabis within the United States and similar restrictions in many jurisdictions outside the country, there is a significant black market for cannabis products. Government-regulated cannabis businesses face competition from black market partici pants and are subject to different market forces than those of the black market. 168 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER X Glossary of Terms Ackrell Capital, LLC a leading independent investment bank focused on the cannabis industry ACMPR Canada’s Access to Cannabis for Medical Purposes Regulations Aeroponics a method of growing plants whereby the roots hang suspended in a nutritional aerosol solution Bankruptcy Code Bankruptcy Reform Act of 1978 BHO Butane hash oil. See Hash oil Bong a device used to smoke cannabis flower via a water chamber through which the smoke passes prior to inhalation; commonly made of glass or plastic BSA Bank Secrecy Act Bud a slang term for cannabis flower Cannabichromene (CBC) a nonpsychoactive cannabinoid believed to have several medicinal benefits, including analgesic, antibacterial, anticancer, antidepressant, antifungal, anti-inflammatory and anti-insomnia Cannabidiol (CBD) a nonpsychoactive cannabinoid believed to have wide-ranging medicinal benefits and therapeutic applications; the second most abundant cannabinoid in cannabis Cannabidiolic acid (CBDA) a nonpsychoactive cannabinoid believed to have several medicinal benefits, including anticancer, antiemetic and anti-inflammatory; the precursor to cannabidiol (CBD) Cannabigerol (CBG) a nonpsychoactive cannabinoid believed to have several medicinal benefits and therapeutic applications; may partially counteract the psychoactive effect of THC and decrease anxiety and muscle tension Cannabigerolic acid (CBGA) a nonpsychoactive cannabinoid that is a precursor to all other cannabinoids, including THC, CBD, CBC and CBG © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 169 Cannabis Investment Report | December 2017 Cannabinoid a class of chemical compounds present in cannabis that act on cannabinoid receptors in cells in the human nervous and immune systems Cannabinol (CBN) a cannabinoid derived from THC degradation; shown to produce some psychoactive effects and believed to have several medicinal benefits, including analgesic, antibacterial, anticonvulsive, anti-inflammatory and anti-insomnia Cannabis a genus of flowering plant consumed for therapeutic, medicinal, social or spiritual purposes and used to produce goods such as rope, paper, clothing and soap; includes three principal cannabis species: Cannabis sativa, Cannabis indica and Cannabis ruderalis CBC See Cannabichromene CBD See Cannabidiol CBDA See Cannabidiolic acid CBG See Cannabigerol CBGA See Cannabigerolic acid CBN See Cannabinol CDSA Canada’s Controlled Drugs and Substances Act Chemovar a plant variety characterized by its chemical content Clone an asexually reproduced cannabis plant genetically identical to the plant from which it was produced CND Commission on Narcotic Drugs, a subsidiary body of the United Nation’s ECOSOC that assists the ECOSOC in supervising the application of international drug control treaties Cole Memo a memorandum published by the DOJ that provides guidance to DOJ attorneys and federal law enforcement about prosecuting cannabis-related federal offenses Concentrates a category of consumer cannabis products; any number of concentrated forms of the active compounds in cannabis; typically an oil or waxlike substance Conventions three international treaties adopted through the United Nations between 1961 and 1988 that address international regulation of cannabis, cannabis derivatives and many other narcotic, psychotropic and similar substances (The Single Convention on Narcotic Drugs of 1961; The Convention on Psychotropic Substances of 1971; and The United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988) Crumble a form of wax concentrate CSA Controlled Substances Act CSE Canadian Securities Exchange Curing a phase of the cannabis cultivation process during which dried cannabis flower undergoes controlled fermentation to develop the flower’s aroma, taste and cannabinoid composition Dab a potent concentrated form of the psychoactive cannabinoid THC 170 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER X Glossary of Terms DEA U.S. Drug Enforcement Agency, an agency of the U.S. Department of Justice Delta-9-Tetrahydrocannabinolic acid (THCA) a nonpsychoactive cannabinoid found abundantly in raw flower; precursor to THC; decarboxylates into THC through the application of intense heat DHHS U.S. Department of Health and Human Services DOJ U.S. Department of Justice DOT U.S. Department of the Treasury Dronabinol a form of chemically synthesized THC included in certain FDA-approved pharmaceuticals; a Schedule II or Schedule III controlled substance under the CSA, depending on its preparation Drying a part of the harvesting phase of cannabis cultivation during which plants are dried; typically occurs at room temperature in a dark space ECDD Expert Committee on Drug Dependence; a committee of the World Health Organization (WHO) tasked with making drug control recommendations to the CND on behalf of the WHO ECOSOC Economic and Social Council, one of the six main organs of the United Nations established under the United Nations charter in 1945 Edible a food- or drink-based infused product intended for oral consumption; commonly baked goods, flavored drinks or candies Endocannabinoid cannabinoids created naturally by the human body Exchange Act Securities Exchange Act of 1934 Extraction a process for extracting active compounds from the cannabis plant; extraction techniques fall into two general categories, solvent-based extraction and solvent-free extraction Farm Bill Agricultural Act of 2014 FDA U.S. Food and Drug Administration, an agency of the DHHS FD&C Act Federal Food, Drug, and Cosmetic Act FinCEN Financial Crimes Enforcement Network, a bureau of the DOT FinCEN Memo a memorandum published by FinCEN outlining how banks and other financial institutions can, consistent with their BSA obligations, provide services to marijuana-related businesses Flower the flower of the cannabis plant, also known as “bud”; the highest concentration of active compounds present in cannabis are found in the flowers of unpollinated female cannabis plants; smoking flower is the most popular method of cannabis consumption Ganja a popular name for cannabis Germination the process by which a dormant seed begins to sprout and grow into a seedling © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 171 Cannabis Investment Report | December 2017 Hash oil a concentrate prepared through extraction using a butane solvent; also known as hashish oil, butane hash or honey oil (BHO), cannabis oil or liquid cannabis Hashish (hash) a concentrate made up of compressed or purified trichomes Hemp the fiber produced from the stalks of the cannabis plant, which can be used to produce goods such as rope, paper and clothing; also refers to varieties of cannabis cultivated to produce industrial hemp products HID lamp a high-intensity discharge lamp; a category of lamp used for indoor cannabis cultivation Hit a slang term for one inhalation from a cannabis smoking device or vaporizer Homeostasis a process by which biological systems tend to maintain internal stability, or balance Human endocannabinoid system a system of nervous and immune system receptors involved in regulating health and physiological functions within the human body Hybrid a cannabis variety that is a genetic cross of two or more different cannabis species or varieties produced through sexual reproduction Hydroponics a method of growing plants whereby the roots grow in a nutrient-rich sand, gravel or liquid growth medium Indica one of three principal cannabis species; indica plants tend to be short and bushy Infused products a category of consumer cannabis products; ingestible products that have been infused with cannabinoids and other active compounds from the cannabis plant IRC Internal Revenue Code IRS Internal Revenue Service Joint a hand-rolled cannabis cigarette Kief a concentrate composed of trichomes that are separated from the cannabis flower by sifting the flower with specialized filtering screens LED a light-emitting diode; a category of lamp used for indoor cannabis cultivation Marijuana a slang term for dried cannabis flower; a legal term for certain parts and derivatives of the cannabis plant defined in the CSA MAUCRSA California’s Medicinal and Adult Use Cannabis Regulation and Safety Act Nabilone a form of chemically synthesized cannabinoid similar to THC included in an FDA-approved pharmaceutical; a Schedule II controlled substance under the CSA Nasdaq Nasdaq Stock Market NDA New Drug Application; an application submitted by a drug manufacturer to the FDA for approval of a drug NYSE New York Stock Exchange 172 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC CHAPTER X Glossary of Terms Oil a category of viscous cannabis concentrates OTC over-the-counter stock market Pipe a device used to smoke cannabis flower; commonly made of glass, wood or metal PPM a private placement memorandum; used by issuers of securities in private offerings to market securities PVPA Plant Variety Protection Act Ruderalis one of three principal cannabis species; ruderalis plants are shaggy and the shortest of the three species SAR Suspicious Activity Report; required to be filed by financial institutions with FinCEN regarding customers engaged in marijuana-related businesses Sativa one of three principal cannabis species; sativa plants are generally tall, thin and wispy SEC U.S. Securities and Exchange Commission Section 280E Internal Revenue Code section 280E Securities Act Securities Act of 1933 Shatter a concentrate prepared through solvent-based extraction; typically has an amber-glass transparency Strain another term for a cannabis plant variety Terpene a class of organic compounds present in cannabis and many other plants; responsible for a plant’s aroma and flavor; believed to have wide-ranging therapeutic applications Tetrahydrocannabinol (THC) delta-9-tetrahydrocannabinol and certain chemical variants, including delta-8-tetrahydrocannabinol; the psychoactive compound in cannabis primarily responsible for the euphoric feeling of being “high”; the most abundant cannabinoid in cannabis; believed to have wide-ranging medicinal benefits and therapeutic applications THC See Tetrahydrocannabinol THCA See Delta-9-Tetrahydrocannabinolic acid Tincture a concentrate suspended in an alcohol solution; usually placed under the tongue using a dropper (sublingual application) Topical an infused product intended for topical application; typically a lotion, balm, cream, lubricant or transdermal patch Trichome a crystalline or hairlike component that secretes cannabinoids, terpenes and other compounds; generally occur all over the cannabis plant, but found in highest concentration on the flower TSX Toronto Stock Exchange TSXV TSX Venture Exchange © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 173 Cannabis Investment Report | December 2017 UN United Nations UNGASS United Nations General Assembly Special Session UNODC United Nations Office on Drugs and Crime USDA U.S. Department of Agriculture USPTO U.S. Patent and Trademark Office Vaporizer a device that heats cannabis flower or concentrate to a temperature at which its active compounds boil and can be inhaled as vapor Variety a plant grouping within a single botanical taxon of the lowest known rank (species) with defining characteristics that distinguish it from any other plant grouping within such rank Wax a category of cannabis concentrates; refers to the softer, opaque oils that have lost their transparency after extraction Weed a slang term for dried cannabis flower WHO World Health Organization, an autonomous intergovernmental organization that collaborates with the United Nations and other organizations on global health matters 174 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC Cannabis Investment Report | December 2017 Disclosures, Disclaimers, Sources and Use This report has been compiled for informational purposes only and is not a research report. This report is not and should not be construed as an offer to sell securities or a solicitation of an offer to buy securities. Readers should not rely on this report in making any investment decision. Readers should not assume that this report is complete and should conduct their own analysis and investigation of the cannabis industry and consult with their own financial, legal, tax and other business advisors before making any investment decision related to the cannabis industry or any company participating therein. The information in this report is of a general nature, and this report should not be construed, relied upon or acted upon as investment, legal, medical, health or tax advice. Readers should obtain advice applying to their circumstances from a qualified attorney or other investment, medical or tax professional before acting or not acting. Ackrell Capital, LLC and its affiliates and their respective directors, officers, employees, agents, representatives, consultants, attorneys, independent contractors and controlling persons (Ackrell Capital, we, us, our) expressly disclaim liability in respect of any action taken or not taken based on information in this report. Any tax-related information contained in this report is not intended as a thoroughgoing analysis and is not to be relied on for any purpose. It may fail to analyze various facts and laws important to any complete, particularized analysis. Readers are urged to consult with their own tax advisors to determine the tax consequences of any planned course of action or nonaction. None of the companies referenced in the report, including those companies referenced in the Top 100 Private Cannabis Companies 2018 and The Green Field 2018, have seen this report prior to publication; the contents of this report (including a company’s inclusion in the Top 100 Private Cannabis Companies 2018 or The Green Field 2018) are not endorsed by any company referenced herein. Some companies referenced in this report may object to being referenced in a document discussing the cannabis industry. Any display of any company’s logo included in this report is intended solely as an efficient method of identifying the company so referenced. Ackrell Capital has made investments in and conducted investment banking and other services for companies referenced in this report and may do so in the future. Readers should be aware that Ackrell Capital may have a conflict of interest that could affect the objectivity of this report. Ackrell Capital does not make any representation or warranty as to the accuracy or completeness of this report. This report relies on and includes information, estimates and opinions from a wide range of sources, both public and private, including surveys, interviews, market databases, market research reports and Ackrell Capital’s own opinions and estimates. The information, estimates and opinions relied on by or included in this report have been obtained from sources we believe to be reliable. Any statement in this report that is not a statement of historical fact (which may be indicated by words such as “believe,” “expect,” “anticipate,” “estimate,” “project,” “predict” and similar expressions) should be considered the opinion or estimate of Ackrell Capital or others. A number of factors could cause actual results or events to differ materially from those indicated by such opinions and estimates. The opinions and estimates included herein or relied on hereby are subject to change without notice, and we assume no obligation to update this report; readers are cautioned to not place undue reliance on such opinions or estimates. While this report includes information developed by others, our original contributions are protected by copyright. We are not looking to prevent others from using our work, however. Others are free to copy and distribute this report or portions of it, so long as they credit Ackrell Capital, LLC. More specifically, we are using the same license used by Wikipedia. Thus, this report is licensed under the Creative Commons Attribution ShareAlike 3.0 License (CC-BY-SA). Others are free to use, re-use, share, reproduce and make derivative works of the report, provided they comply with the requirements of the CC-BY-SA, which can be found at: https:// creativecommons.org/licenses/by-sa/3.0. © 2017 Ackrell Capital, LLC | Member FINRA / SIPC 175 Cannabis Investment Report | December 2017 Ackrell Capital Cannabis Team Mike Ackrell Founder mackrell@ackrell.com Mike Ackrell founded Ackrell Capital in 2003. Previously, Mr. Ackrell was the Head of ABN AMRO’s U.S. Technology Investment Banking Group and the Head of Investment Banking at WR Hambrecht+Co. He also was a Senior Vice President in the Technology Investment Banking Group of Donaldson, Lufkin & Jenrette, where he began his investment banking career in 1988. Mr. Ackrell has completed more than 150 financing transactions, including more than 50 initial public offerings, and more than 100 M&A transactions, totaling more than $15 billion in value. He serves on the Board of Directors of a number of companies, including American Giant, Scrubbed and Vator.tv. Mr. Ackrell holds a B.S. in Economics, summa cum laude, with majors in Finance and Accounting, from the Wharton School of the University of Pennsylvania. Tim Coxon General Counsel tcoxon@ackrell.com Tim Coxon joined Ackrell Capital in 2017 after serving as the firm’s legal counsel for more than five years. Previously, Mr. Coxon was a corporate finance attorney in Silicon Valley focused on venture capital fund formation, early stage company financings, mergers and acquisitions and related areas of tax and securities law. He has advised dozens of VC firms on fund and management-level structuring and portfolio company investment transactions, and has advised private companies in M&A transactions valued at more than $1.5 billion. Mr. Coxon also has worked as a consultant performing financial and economic analysis for use in corporate litigation and regulatory matters, and taught college level mathematics for more than 13 years, including 7 years as an adjunct statistics professor for the M.B.A. program at Santa Clara University. Mr. Coxon holds a J.D. from the Santa Clara University School of Law, an M.A. in Mathematics from San Francisco State University, and a B.A. in Mathematics from the University of Texas at Austin. Bryan Castillo Partner bcastillo@ackrell.com Jeff Mathews Partner jmathews@ackrell.com Bryan Castillo joined Ackrell Capital in 2015. Previously, Mr. Castillo served as an adviser to governments on economic and foreign policy. He has more than 10 years of investment banking experience focused primarily on cross-border transactions spanning Asia, Europe and the Middle East. Mr. Castillo has experience in a number of industries, including agriculture, cleantech, consumer, energy, media, real estate and technology. He has advised on more than 50 financing transactions, primarily with state-owned enterprises and private companies. Mr. Castillo works closely with several family offices on private equity and venture capital investments. Mr. Castillo holds a B.S. in Economics from the Pennsylvania State University. Jeff Mathews joined Ackrell Capital in 2015. Previously, Mr. Mathews was a Director with Seven Hills Group, a boutique investment bank focused on middle-market technology companies. He has more than 15 years of investment banking experience and was also an Associate in the Technology Investment Banking Groups at Deutsche Bank and Lehman Brothers. He has advised on a broad range of financings and M&A transactions across a variety of technology industries totaling more than $10 billion in value. Mr. Mathews holds a B.A. in Economics from the University of Chicago. 176 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC ACKRELL CAPITAL The green field 2018 Cultivation ���������� Production Equipment and Supplies Production and Testing Services Dispensaries ������������ E-Commerce Distribution Services ACKRELL CAPITAL The green field 2018 Consumer Products Flower and Concentrates Infused Products Vaporizers and Accessories Pharmaceuticals Business Solutions Digital Media Business Software Business Services Online Content Online Directories and Networking Inclusion in The Green Field 2018 does not represent an investment recommendation or an endorsement of any particular company. Our intent in providing this industry landscape is to provide a graphical representation of the cannabis industry, its segments and participants. This landscape is necessarily subjective. Numerous companies operate in multiple segments. None of the companies referenced in The Green Field 2018 have seen The Green Field 2018 prior to publication; therefore, there is no endorsement of The Green Field 2018 or the inclusion in The Green Field 2018 by any company referenced. In addition, any display of any company’s logo is meant solely as an efficient communications method of identifying the company so referenced. For additional disclosures and disclaimers, see page 175. ACKRELL CAPITAL TOP 100 PRIVATE CANNABIS COMPANIES 2018 AEssenseGrows Défoncé Jetty Extracts River Collective Ample Organics Dixie Elixirs Kikoko Rubicon Organics Apeks Supercritical Dosist KIVA Confections S2S Development The Apothecarium Eaze Solutions Korova SC Laboratories Auntie Dolores Eel River Organics LeafLink Scrubbed Baker Technologies Elemental Wellness Leafly SPARC BAS Research Euflora Level Blends Spectrum King BDS Analytics Evolve Therapeutics LivWell Enlightened Health Steep Hill Labs Beboe Evoxe Laboratories Lunchbox Alchemy StickyGuide Berkeley Patients Group Flow Kana Mary's Medicinals Strainz BioTrackTHC Flowhub Meadow Teewinot Life Sciences Bloom Farms FunkSac Merry Jane Tikun Olam Brewbudz Garden State Dispensary MiNDFUL Treez Bud and Bloom GFarmaLabs MJ Freeway Trellis Calyx Brands Gold Coast Extracts MJardin Trulieve Cannabis Reports Green Dot Labs MM Acquisition Co. Utopia Farms CannaCraft Green Flower Media Native Roots VapeWorld CannaKorp Green Rush New Vansterdam Vapexhale Colorado Harvest Company The Green Solution Northwest Cannabis Solutions VCC Brands Columbia Care Harborside Health Center NWT Holdings (Firefly) Vuber Confident Cannabis Harvest Organa Brands Wana Brands Cultivation Technologies Headset PAX Labs Web Joint Cura Cannabis Solutions HelloMD PharmaCielo Weedguide CW Analytical Humboldt Legends PRØHBTD Media Weedmaps Deep Cell Incense Specialties Qind Wellness Connection of Maine None of the companies referenced in the report, including those companies referenced in the Top 100 Private Cannabis Companies 2018 and The Green Field 2018, have seen this report prior to publication; therefore, there is no endorsement of the contents of this report or the inclusion in the Top 100 Private Cannabis Companies 2018 or The Green Field 2018 by any company referenced. In addition, any display of any company’s logo included in this report is meant solely as an efficient communications method of identifying the company so referenced. Inclusion in the Top 100 Private Cannabis Companies 2018 and the Green Field 2018 does not represent an